The International Cytokines & Interferon Society (ICIS) thrives on the invaluable contributions of individuals who generously devote their time and expertise to the Society. As we look to the future, we invite you, our members, to consider stepping into leadership roles that will drive the field of cytokine and interferon research to new heights. [READ MORE]
Dr. Judith Allen is a professor of Immunobiology at the University of Manchester. The Allen laboratory investigates the host immune response to parasite infection with a focus on type 2 immunity, the response mammals characteristically make to large multicellular parasites (helminths). Nobel Laureate Dr. Drew Weissman is a professor of Medicine at the Perelman School of Medicine, University of Pennsylvania. Dr. Weissman, in collaboration with Nobel Laureate Dr. Katalin Karikó, discovered the ability of modified nucleosides in RNA to suppress activation of innate immune sensors and increase the translation of mRNA containing certain modified nucleosides. [READ MORE]
Dr. Brian Kim on the left, and Dr. David Artis on the right at their visit in February to Allen Institute in Seattle, WA. Photo from Dr Kim’s Twitter/X account.
Some dermatological disorders such as atopic dermatitis, alopecia areater, and vitiligo have few treatments available due to the lack of effective medications currently on the market. However, this might change soon with the formation of a new biotech entity called Alys Pharmaceuticals, Inc. that launched on 12th of February. It started with a substantial 100-million-dollar investment from Medicxi, the European healthcare investment fund, with the goal of transforming the treatment paradigm for several dermatology indications of significant prevalence and major unmet need. Alys, based in Boston and Geneva, is the combination of the assets and platforms of Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics, and has a world class leadership team that brings together experts across dermatology and advanced scientific fields. [READ MORE]
Mark Travis (Univ. of Manchester) is not an immunologist by training…. I did my BSc in Biochemistry and Genetics at Lancaster University, then a PhD in Protein Biochemistry at the University of Manchester, working on how integrins bind to ligands and signal. I then did my post-doc at UCSF, where I started working on integrins that bind and activate the cytokine TGF-beta. I made a conditional knockout mouse while I was there that got an intestinal inflammation phenotype, so I quickly morphed into becoming a mucosal immunologist…. which I have been ever since. [READ MORE]
In both the clinic and the lab, I study inflammatory complications in people with HIV and the impact of CD4 lymphopenia in HIV and other conditions, specifically a rare disorder of unclear etiology called idiopathic CD4 lymphopenia (ICL). Lots of work on biomarkers and immune-based therapies in these conditions hence my affinity for cytokines. I currently work at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) and am the incoming chief of the Laboratories of Immunoregulation and Molecular Microbiology. [READ MORE]
Candidates may apply or be nominated for MORE THAN ONE YOUNG INVESTIGATOR AWARD using the Nomination/Application Form below as well as for a Cytokines 2024 Travel Award (applied for via the Cytokines 2024 Abstract Submission), but will not be awarded more than one award in a given year. Deadline for submitting Young Investigator award application is extended to Wednesday, 3 April, 2024.
Nominations by mentors and/or colleagues for the Young Investigator Awards or self-applicants, please use one form for each candidate for ALL 2024 Young Investigator Award nominations or applications. Candidates may be nominated for more than one award using the same form (multi-select), but please use a separate form for each candidate. [READ MORE]
ICIS Council is proud of the high level of award winners at every career stage, and it is a source of satisfaction that the Awards Committee has to choose between so many inspiring candidates. Consider the careers and contributions to our field that past ICIS award winners have and continue to make and it is clear how important it is that we recognize those who are revolutionizing modern medicine and leading to new treatments in autoimmune diseases, cancer and infectious diseases. [READ MORE]
Princeton University and the Princeton Brance of the Ludwig Institute for Cancer Research announce the appointment of Lydia Lynch as Full Professor in the Department of Molecular Biology a full member of the Princeton Branch of the Ludwig Institute for Cancer Research. Professor Lynch is a former Mid-Career Award Winner and on the Nominating Committee of the International Cytokine & Interferon Society and will be leaving her position as Associate professor at Harvard Medical School and Brigham and Women’s Hospital in Boston, Massachusetts. [READ MORE]
Ilja Striz serves as the head of the Department of Clinical and Transplant Immunology at the Institute for Clinical and Experimental Medicine (IKEM). He is also a Professor of Immunology at the 1st Medical Faculty of Charles University in Prague and holds the positions of Vice-President in the Czech Society of Allergology and Clinical Immunology and the Czech Immunological Society. [READ MORE]
I started attending ICIS meetings in 2017 and learned a great deal about cytokines and made many friends. I have also served as a Council Member of ICIS since last year and am currently leading the local organizing committee for Cytokines 2024 & KAI 2024. What has struck me the most over the years of my engagement with ICIS is the great emphasis the ICIS leadership places on helping young scientists and the loyalty of ICIS members to the society. It is like once you are in, you belong to the family. I wish I had joined ICIS earlier in my career.
What book or TV show are you reading/watching right now that you recommend? “Breaking through: My life in Science” by Katalin Kariko. It shows how important perseverance is in science. It is a powerful and inspiring book and, at the same time, an easy read for non-native English speakers like me.” [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
